Louisiana's Novel 'Subscription' Model For Pricey Hepatitis C Drugs Gains Approval
Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit.